DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

Bal Pharma Limited — Shareholders meeting

NSE 26 Aug·26 Aug 2026, 12:09 pm

BAL Pharma

Bal Pharma Limited has announced that its upcoming Annual General Meeting (AGM) is scheduled for September 24, 2026. This meeting is a standard corporate requirement where the company's board and shareholders will discuss and approve the annual financial results and other key business matters.

For investors, this event is important as it provides transparency into the company's performance and future strategy. It is a key date to watch for updates on the company's financial health and any significant announcements that could impact the stock.

Investors should look out for the company's financial statements and any strategic plans discussed during the meeting. The outcome of the AGM can influence market sentiment and the stock's performance in the days following the event.